Coronavirus
Moderna Wants ‘Flexibility’ in Covid Booster Eligibility
Moderna CEO Stephane Bancel told CNBC on Thursday the drugmaker wanted to provide U.S. regulators “flexibility” in determining eligibility for a fourth Covid vaccine dose.
Moderna submitted its application last week for a so-called second booster, asking the Food and Drug Administration to clear the additional shot for all Americans ages 18 and up.
The biotech firm’s request was considerably more broad than competing mRNA vaccine maker Pfizer, whose fourth-dose application covered only people 65 and older.
